Search

Author/Creator Yang, J. C.

1. A phase 3b study of sofosbuvir plus ribavirin in treatment‐naive and treatment‐experienced Korean patients chronically infected with genotype 2 hepatitis C virus. Issue 5 (10th February 2016)

Authors:
Ahn, S. H.; Lim, Y. S.; Lee, K. S.; Paik, S. W.; Lee, Y. J.; Jeong, S. H.; Kim, J. H.; Yoon, S. K.; Yim, H. J.; Tak, W. Y.; Han, S. Y.; Yang, J. C.; Mo, H.; Mathias, A.; Han, L.; Knox, S. J.; Brainard, D. M.; Kim, Y. J.; Byun, K. S.; Kim, Y. S.
Journal:
Journal of viral hepatitis
Issue:
Volume 23:Issue 5(2016)
Page Start:
358
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. GS‐9857 in patients with chronic hepatitis C virus genotype 1–4 infection: a randomized, double‐blind, dose‐ranging phase 1 study. Issue 8 (9th March 2016)

Authors:
Rodriguez‐Torres, M.; Glass, S.; Hill, J.; Freilich, B.; Hassman, D.; Di Bisceglie, A. M.; Taylor, J. G.; Kirby, B. J.; Dvory‐Sobol, H.; Yang, J. C.; An, D.; Stamm, L. M.; Brainard, D. M.; Kim, S.; Krefetz, D.; Smith, W.; Marbury, T.; Lawitz, E.
Journal:
Journal of viral hepatitis
Issue:
Volume 23:Issue 8(2016)
Page Start:
614
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗